Helicobacter pylori infection.
Conditions
Interventions
Intervention 1: Intervention group: Atrostatin 40 mg at night for 14 days with standard treatment (including a Bismuth Subcitrate 240 mg tablet, a Pantoprazole 40 mg tablet, a metronidazole 500 mg tab
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 18 years or older Indication for Helicobacter pylori eradication
Exclusion criteria
Exclusion criteria: liver disease at the same time Diabetes at the same time Statin use in 6 months History of gastric surgery History of treatment for eradication of H. pylori Antibiotics, PPIs, histamine receptor blockers, anti-inflammatory and non-steroidal drugs, bismuth salts in the past month Allergy to any of the antibiotics used in the study Gastrointestinal malignancy Active gastrointestinal bleeding Pregnant and lactating History of radiation therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori eradication. Timepoint: After 4 weeks of completion of treatment. Method of measurement: 38/5000Evaluation of Helicobacter pylori fecal antigen. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug Side effects. Timepoint: During and after the course of treatment. Method of measurement: Ask the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Reza Mohammad Hosseini Azar
Oroumia University of Medical Sciences
Outcome results
None listed